192 related articles for article (PubMed ID: 37630190)
1. Utilizing Proteomic Approaches to Uncover the Neuroprotective Effects of ACE Inhibitors: Implications for Alzheimer's Disease Treatment.
Yang MH; Ho TC; Chang CC; Su YS; Yuan CH; Chuang KP; Tyan YC
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630190
[TBL] [Abstract][Full Text] [Related]
2. The implications of angiotensin-converting enzymes and their modulators in neurodegenerative disorders: current and future perspectives.
Kaur P; Muthuraman A; Kaur M
ACS Chem Neurosci; 2015 Apr; 6(4):508-21. PubMed ID: 25680080
[TBL] [Abstract][Full Text] [Related]
3. The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer's disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status.
Ouk M; Wu CY; Rabin JS; Jackson A; Edwards JD; Ramirez J; Masellis M; Swartz RH; Herrmann N; Lanctôt KL; Black SE; Swardfager W
Alzheimers Res Ther; 2021 Feb; 13(1):43. PubMed ID: 33573702
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibitors and Alzheimer's disease progression in older adults: results from the Réseau sur la Maladie d'Alzheimer Français cohort.
Soto ME; van Kan GA; Nourhashemi F; Gillette-Guyonnet S; Cesari M; Cantet C; Rolland Y; Vellas B
J Am Geriatr Soc; 2013 Sep; 61(9):1482-8. PubMed ID: 24000874
[TBL] [Abstract][Full Text] [Related]
5. A clinical dose of angiotensin-converting enzyme (ACE) inhibitor and heterozygous ACE deletion exacerbate Alzheimer's disease pathology in mice.
Liu S; Ando F; Fujita Y; Liu J; Maeda T; Shen X; Kikuchi K; Matsumoto A; Yokomori M; Tanabe-Fujimura C; Shimokata H; Michikawa M; Komano H; Zou K
J Biol Chem; 2019 Jun; 294(25):9760-9770. PubMed ID: 31072831
[TBL] [Abstract][Full Text] [Related]
6. Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease.
Yamada K; Uchida S; Takahashi S; Takayama M; Nagata Y; Suzuki N; Shirakura S; Kanda T
Brain Res; 2010 Sep; 1352():176-86. PubMed ID: 20627092
[TBL] [Abstract][Full Text] [Related]
7. Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
Fournier A; Oprisiu-Fournier R; Serot JM; Godefroy O; Achard JM; Faure S; Mazouz H; Temmar M; Albu A; Bordet R; Hanon O; Gueyffier F; Wang J; Black S; Sato N
Expert Rev Neurother; 2009 Sep; 9(9):1413-31. PubMed ID: 19769454
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin Receptor Blockers Are Associated With a Lower Risk of Progression From Mild Cognitive Impairment to Dementia.
Deng Z; Jiang J; Wang J; Pan D; Zhu Y; Li H; Zhang X; Liu X; Xu Y; Li Y; Tang Y;
Hypertension; 2022 Oct; 79(10):2159-2169. PubMed ID: 35766029
[TBL] [Abstract][Full Text] [Related]
9. [The benefit of angiotensin converting enzyme inhibitor for geriatric syndrome in the elderly].
Ebihara T; Ohrui T; Ebihara S; Tsuji I; Sasaki H; Arai H
Nihon Ronen Igakkai Zasshi; 2007 Jul; 44(4):448-51. PubMed ID: 17827800
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Rescue Memory Defects in
Lee SH; Gomes SM; Ghalayini J; Iliadi KG; Boulianne GL
eNeuro; 2020; 7(6):. PubMed ID: 33060184
[TBL] [Abstract][Full Text] [Related]
11. Effects of centrally acting angiotensin converting enzyme inhibitors on functional decline in patients with Alzheimer's disease.
O'Caoimh R; Healy L; Gao Y; Svendrovski A; Kerins DM; Eustace J; Kehoe PG; Guyatt G; Molloy DW
J Alzheimers Dis; 2014; 40(3):595-603. PubMed ID: 24496072
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive mechanism of action of the novel angiotensin converting enzyme inhibitor benazepril. Effect on isolated vascular preparations.
Kuroda K; Fukuda Y; Nakao K; Inukai T
Arzneimittelforschung; 1990 Sep; 40(9):968-73. PubMed ID: 2080946
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of Angiotensin-Converting Enzyme Inhibitors in Patients with Alzheimer's Disease Dementia.
de Oliveira FF; Chen ES; Smith MC; Bertolucci PHF
Curr Alzheimer Res; 2018 Feb; 15(4):386-398. PubMed ID: 29034839
[TBL] [Abstract][Full Text] [Related]
14. ACE Inhibitors Improve Skeletal Muscle by Preserving Neuromuscular Junctions in Patients with Alzheimer's Disease.
Qaisar R; Karim A; Iqbal MS; Alkahtani SA; Ahmad F; Kamli H
J Alzheimers Dis; 2023; 94(2):641-650. PubMed ID: 37334602
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin Converting Enzyme Inhibitors Ameliorate Brain Inflammation Associated with Microglial Activation: Possible Implications for Alzheimer's Disease.
Torika N; Asraf K; Roasso E; Danon A; Fleisher-Berkovich S
J Neuroimmune Pharmacol; 2016 Dec; 11(4):774-785. PubMed ID: 27562846
[TBL] [Abstract][Full Text] [Related]
16. Acute and chronic effects of angiotensin-converting enzyme inhibitors on tissue angiotensin-converting enzyme.
Chai SY; Perich R; Jackson B; Mendelsohn FA; Johnston CI
Clin Exp Pharmacol Physiol Suppl; 1992; 19():7-12. PubMed ID: 1327597
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetic analyses of variations of measures of cardiovascular risk in Alzheimer's dementia.
de Oliveira FF; Berretta JM; de Almeida Junior GV; de Almeida SS; Chen ES; Smith MC; Bertolucci PHF
Indian J Med Res; 2019 Sep; 150(3):261-271. PubMed ID: 31719297
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme inhibitors and the reduced risk of Alzheimer's disease in the absence of apolipoprotein E4 allele.
Qiu WQ; Mwamburi M; Besser LM; Zhu H; Li H; Wallack M; Phillips L; Qiao L; Budson AE; Stern R; Kowall N
J Alzheimers Dis; 2013; 37(2):421-8. PubMed ID: 23948883
[TBL] [Abstract][Full Text] [Related]
19. Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers.
Ouk M; Wu CY; Rabin JS; Edwards JD; Ramirez J; Masellis M; Swartz RH; Herrmann N; Lanctôt KL; Black SE; Swardfager W;
Neurobiol Aging; 2021 Apr; 100():22-31. PubMed ID: 33461049
[TBL] [Abstract][Full Text] [Related]
20. Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: Past, present and future.
Gouveia F; Camins A; Ettcheto M; Bicker J; Falcão A; Cruz MT; Fortuna A
Ageing Res Rev; 2022 May; 77():101612. PubMed ID: 35346852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
